MyFinsight
Home
Blog
About
Contact
Download
Download image
Short-term investments
$1,387,000K
Cash and cash
equivalents
$173,959K
Prepaid expenses and
other current assets
$66,402K
Long-term investments
$881,664K
Property and equipment,
net
$257,370K
Other assets
$118,847K
Operating lease
right-of-use assets
$116,009K
Restricted cash
$1,466K
Total current assets
$1,627,361K
Total noncurrent
assets
$1,375,356K
Total assets
$3,002,717K
Total liabilities and
stockholders' equity
$3,002,717K
Total stockholders'
equity
$2,685,510K
Total liabilities
$317,207K
Accumulated deficit
-$2,154,947K
Additional paid-in capital
$4,838,736K
Total current
liabilities
$205,750K
Operating lease
liabilities long-term
$111,357K
Other liabilities
$100K
Accumulated other
comprehensive income (loss)
$1,587K
Common stock, 0.001 par
value 500,000,000...
$134K
Accrued contract
manufacturing expenses
$74,654K
Accounts payable
$70,904K
Accrued expenses
$31,068K
Accrued compensation
$23,000K
Operating lease
liabilities current
$6,124K
Back
Back
Balance Sheet
source: myfinsight.com
Vaxcyte, Inc. (PCVX)
Vaxcyte, Inc. (PCVX)